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Abstract 
Objective: Obesity and cardiovascular disease (CVD) are closely related and have become 
increasingly prevalent in Korea. Asians are more prone to obesity-related co-morbidities than 
Caucasians, even at lower body mass index (BMI) and/or smaller waist circumference (WC) 
values. Nevertheless, little is known regarding the association of WC with the risk of CVD in 
non-Caucasian populations. The authors conducted a prospective cohort study of WC and the 
risk of CVD in the Korean Heart Study. 
Methods: We examined the association of WC to CVD incidence among 53,026 Korean adults 
(30,152 men, 22,874 women) with no history of CVD and/or cancer. During a mean follow-up of 
8.6 years, 2,722 incident cases of atherosclerotic cardiovascular disease (ASCVD) including 
1,383 cases of ischemic heart disease (IHD) and 1,012 cases of stroke were documented.      
Results:  Average WC at baseline was 84.0±8.2 cm in men and 75.2±8.9 cm in women. After 
adjustment for age and BMI, WC was significantly associated with cardiovascular risk factors (P 
<.001). In men, a WC of ≥91 cm was associated with an ASCVD hazard ratio (HR) of 1.62 (95% 
confidence interval (CI): 1.25, 2.10) and an IHD HR of 1.70 (95% CI: 1.19, 2.42) in comparison 
with a WC of <78 cm even after further adjustment for BMI and traditional risk factors (P for 
trend = 0.0118, 0.0139 respectively). In women, the progressive associations of WC with 
ASCVD, IHD and stroke were observed. These associations were however attenuated after 
further adjustment for BMI and traditional risk factors. The multivariable HRs for ASCVD, IHD, 
and stroke increased with higher WC in both men and women.   
Conclusions: Central obesity significantly and independently contributes to cardiovascular 
outcomes in Korean men and women.  
Key words: Waist Circumference, Central Obesity, Cardiovascular Disease  
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INTRODUCTION  
 
The prevalence and incidence of obesity are increasing rapidly in both developed and 
developing countries (1). Abdominal obesity has also been found to be an independent   
contributor to cardiovascular disease (CVD) at a given level of obesity (2-4). Moreover, 
abdominal obesity promotes insulin resistance and leads to metabolic syndrome (MetS) (5). 
MetS is recognized as a cluster of cardiovascular risk factors that frequently coincide with 
insulin resistance and hyperglycemia (6). Recently, the World Health Organization (WHO) 
established a different criteria for the clinical diagnosis of the MetS, compared to the National 
Cholesterol Education Program (NCEP), with lower waist circumference (WC) levels in Asian 
populations compared to Caucasian populations (7-9). Asians are more prone to obesity-related 
co-morbidities than Caucasians, even at lower BMI and/or smaller WC values (10, 11).  
 In Korea, proportionate morbidity and mortality from ASCVD have increased markedly 
between 1981 and 2003 (12). The death rates from stroke ranked second in mortality for both 
men and women in Korea. The death rate from IHD has increased by 122.8% over the last 
decade (13).  Nevertheless, little information is available on the association of WC with CVD 
incidence in Korean population. Therefore, we had collected to form the study population for a 
cohort study from 19 heath promotion centers nationwide where those additional CVD risk 
factors were available. We have labeled this study as the Korean Heart Study (KHS). The KHS 
conducted by Korean metabolic syndrome research initiatives (KMSRI) which commenced in 
December 1st 2005, were to develop the Korean Cardiovascular Disease Prediction Model using 
previously collected data from 19 health promotion centers, collaborating with the Korean 
society of cardiology and the National Health Insurance Corporation. The objective of the study 
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was to address the relation between the level of WC and the risk of CVD in the subgroup of the 
KHS.  
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METHODS 
Study Population   
The KHS cohort includes the 476,529 Korean (290,509 men and 186,020 women) over 
the age of 20 who had undertaken medical examinations. Of the study participants, 11,141 
participants (2.3%) between 1993 and 1995, 24,226 participants (5.1%) in 1996, 38,159 
participants (8.0%) in 1997, 39,906 participants (8.4%) in 1998, 42,417 participants (8.9%) in 
1999, 73,883 participants (15.5%) in 2000, 90,051 participants (18.9%) in 2001, 52,057 
participants (10.9%) in 2002, 47,543 participants (10.0%) in 2003 and 57,146 participants 
(12.0%) in 2004 were enrolled. Of the 476,529 participants, 57,708 people who had data on 
waist circumference were included for the present study. 
 To avoid confounding of the association between WC and the risk of preexisting disease, 
4,329 individuals who reported history of cancer or ASCVD (IHD or stroke) were excluded. In 
addition, 353 individuals with missing information about gender, smoking status, alcohol intake 
or exercise were excluded. The final sample included 53,026 subjects.     
Because the study involved data that were routinely collected, consent was not 
specifically obtained. The institutional review boards of Yonsei University and each institution 
participated to this study approved the study.   
 
Data Collection  
 Sociodemographic characteristics, smoking status, alcohol intake, and exercise habits 
were assessed by questionnaire. Height and weight were measured using bioelectrical impedance 
analysis (Inbody 3.0, Biospace, Korea, 2001) following overnight fast. BMI was calculated as 
weight divided by height squared (kg/m2) (14). WC was measured at middle part between the 
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lower rib and iliac crest by a trained nurse. Blood pressure was measured by a semi-automated 
blood pressure monitor (TM-2650A, PMS Instruments, Tokyo, Japan) after a rest of at least 15 
min. 
 Venous blood was drawn following an 8-h overnight fast and 24-h abstinence from 
vigorous activity. Standard enzymatic measurements of total cholesterol, triglycerides, high-
density lipoprotein (HDL) cholesterol, and fasting glucose were made on fresh serum samples by 
oxidase–peroxidase enzymatic assay (TBA-200FR, Toshiba, Tokyo, Japan). 
 
Outcome definition and follow-up procedures  
 We followed the NCEP-ATP III guidelines to define central obesity (≥102 cm of WC for 
men and ≥88 cm of WC for women) (8). We also evaluated the WC according to the report of 
the joint WHO/IASO/IOTF committee, who propose that the WC values of 90 cm for men and 
80 cm for women be used as Asian-specific WC cutoff points for central obesity (15). We also 
used the WC cutoff recently established as ethnically appropriate for central obesity specifically 
in Korean adults which was set at 90 cm for men and 85 cm for women (16).   
 The principal outcome variables were morbidity from: (1) total ASCVD included by 
hypertensive disease (ICD 9 codes 401–405), IHD (410–414), hemorrhagic stroke (430–432), 
thrombotic stroke (433–434), other stroke (435–438), other heart disease likely related to 
ASCVD (426–429), and other vascular disease (440–444).  (2) IHD alone (ICD 9 codes 410–
414), along with acute myocardial infarction (AMI) alone (410) and angina pectoris (AP) alone 
(413), and (3) Stroke alone (ICD 9 codes 430–438). 
 In Korea, professionally trained and certified medical chart recorders abstracted charts 
and assigned discharge diagnoses in a standardized fashion using WHO codes for common 
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diseases such as stroke and myocardial infarction. The mean follow-up period was 8.59 years, 
through 30 June 2009. Consequently, follow-up accrual began on 1 January of the calendar year 
(2005) following the year (2004) in which the survey form was completed.  
 
Statistical Analysis 
 We examined the bivariate relationship between WC and traditional cardiovascular risk 
factors using Pearsons correlation analyses and partial correlations, controlling for age and BMI. 
Cox proportional hazards models were used to assess the independent effects of WC on ASCVD, 
IHD, and stroke. All models included adjustment for age, smoking status, alcohol consumption 
and exercise. In addition, we also fitted models with further adjustment for BMI, and traditional 
risk factors such as systolic blood pressure, fasting glucose and total cholesterol levels to 
evaluate the effect of WC that is not explained by BMI and cardiovascular risk factors. We also 
used Cox proportional hazards models to compare the guidelines of central obesity on ASCVD, 
IHD, and stroke, controlling for age, smoking status, alcohol consumption and exercise. In all 
analyses, a two-sided α level of 0.05 was considered statistically significant. All analyses were 
conducted with the use of SAS software, version 9 (SAS institute Inc., Cary, NC, USA). 
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RESULTS 
Demographic Characteristics   
Demographic characteristics are presented in Table 1. A total of 53,026 individuals 
participated, 30,152 men (56.9%) and 22,874 women (43.1%). The mean age of the study 
participants was 43.9 ± 10.5 yr. About 36% of the men were among 40- to 49-year old and 33% 
of the women were among 30- to 39-year old. The mean WC was 84.0±8.2 cm in men and 
75.2±8.9 cm in women. Almost 46% of men had WC of 80-89 cm and 43% of women had WC 
of 70-79 cm (Fig. 1). Men, in comparison to women, had higher smoking and alcohol drinking 
rates.  
Over 8.6 years of follow-up, there were 2,722 incident cases of ASCVD (1,676 in men, 
1,046 in women), including 1,383 cases of IHD (914 in men, 469 in women) and 1,012 cases of 
stroke (601 in men, 411 in women).  
 
Correlation between cardiovascular risk factors and waist circumference 
Systolic blood pressure and diastolic blood pressure were positively correlated with WC 
in men and women, and these associations persisted after controlling for age and BMI. In both 
men and women, the negative relation of HDL cholesterol to WC remained significant even after 
adjusting for age and BMI. The levels of total cholesterol, triglyceride and fasting glucose still 
increased progressively with WC after adjustment for age and BMI in men and women (Table 2). 
                                    
Hazard Ratios of cardiovascular disease by waist circumference categories in men 
 The independent effects of WC on ASCVD, IHD, and stroke were examined in Cox 
proportional hazards models that simultaneously controlled for age, smoking status, alcohol 
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consumption and exercise, and with further adjustment for BMI and traditional risk factors in 
men. To assess the relationship between WC and ASCVD by level of WC, we divided the cohort 
into quintiles of WC (<78, 78-82.9, 83-86.9, 87-90.9, ≥91 cm). In these quintiles, the number of 
IHD events was 82, 159, 169, 226, and 278 respectively, while the number of ASCVD events 
was 164, 320, 328, 374, and 490 respectively.  
 As Table 3 shows, the HR (95% CI) for any ASCVD event was 2.32 (1.94-2.78) in the 
highest quintile of WC compared to the lowest quintile of WC after controlling for age, smoking 
status, alcohol consumption and exercise. Additional adjustment for BMI and traditional risk 
factors remained highly significant, albeit attenuated in men (HR = 1.62, 95% CI: 1.25-2.10). 
Compared to the lowest quintile of WC, the HR (95% CI) for any IHD event was 2.68 
(2.09-3.44) in the highest quintile of WC after controlling for age and behavioral factors, still 
significant after further adjustment for BMI and traditional risk factors (HR = 1.70, 95% CI: 
1.19-2.42). For stroke, the corresponding HR (95% CI) was 1.82 (1.37-2.43) in the highest 
quintile of WC. Additional adjustment for BMI and traditional risk factors however altered the 
HR results for stroke. There were strong and graded relations of increasing WC with ASCVD 
and IHD in men, as shown in Table 3 (P for trend = 0.0118, 0.0139 respectively).  
 
Hazard Ratios of cardiovascular disease by waist circumference categories in women 
In women, the independent effects of WC on ASCVD, IHD, and stroke were examined in 
Cox proportional hazards models that simultaneously controlled for age, smoking status, alcohol 
consumption and exercise as well. In addition, the models were further adjusted for BMI and 
traditional risk factors. To assess the relationship between WC and ASCVD by level of WC, we 
divided the cohort into quintiles of WC (<68, 68-71.9, 72-75.9, 76-81.9, ≥82 cm). In these 
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quintiles, the number of ASCVD events was 77, 96, 186, 288, and 399 respectively, while the 
number of stroke events was 32, 37, 75, 112, and 155 respectively.  
 As Table 4 shows, the HR (95% CI) for any ASCVD event was 2.09 (1.61-2.70) in the 
highest quintile of WC compared to the lowest quintile of WC after controlling for age, smoking 
status, alcohol consumption and exercise. Additional adjustment for BMI and traditional risk 
factors attenuated the HR results for ASCVD in women.  
Compared to the lowest quintile of WC, the HR (95% CI) for IHD was 2.34 (1.59-3.44) 
in the highest quintile of WC after controlling for age and behavioral factors. Further adjustment 
for BMI and traditional risk factors altered the HR results for IHD, non-significant. For stroke, 
the corresponding HR (95% CI) was 1.74 (1.16-2.59) in the highest quintile of WC. However, 
additional adjustment for BMI and traditional risk factors also attenuated the results for stroke in 
women. As shown in Table 4, the progressive associations of WC with ASCVD, IHD and stroke 
were observed in women., These associations were however attenuated after further adjustment 
for BMI and traditional risk factors.  
 
Comparison of waist circumference by using various guidelines for central obesity  
To assess the relationship between central obesity and CVD, we divided the cohort into 
two groups of WC using different criteria for central obesity among men and women. Hazard 
ratios of various guidelines for central obesity on ASCVD, IHD, and stroke events were analyzed 
after controlling for age, smoking status, alcohol intake and exercise. According to Korean 
guideline for central obesity, the HR for ASCVD was 1.47 (95% CI 1.33-1.63) in men and 1.56 
(95% CI 1.36-1.78) in women. As Table 5 shows, the multivariable HRs increased with higher 
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WC for events from ASCVD, IHD and stroke in both men and women. The HR of IHD to WC 
tended to be higher than those of ASCVD and stroke. 
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DISCUSSION 
Our results show that WC is significantly associated to CVD risk factors in this Korean 
cohort, over and above what can be explained by BMI alone. Results also show that central 
obesity is an important and independent contributor to future CVD in this Asian population. The 
importance of metabolic risk factors and central obesity has been recognized recently and many 
diagnostic criteria have been established for MetS. The IDF proposed that central obesity, as 
assessed by WC cutoff values specific for ethnicity and gender, should be an essential 
component for the diagnosis of MetS (17). As above mentioned, Asian populations may have a 
different fat distribution pattern than Western populations and may be more prone to central 
obesity, even at low BMI levels (10, 18). While the precise reasons for these differences are not 
completely understood (18), at similar BMI, Asians will tend do have less muscle mass and 
connective tissue than Caucasian subjects and more fat mass (19).  
A previous study according to obesity type indicated that any type of obesity may be 
metabolically harmful (20), and serves as a signal of a constellation of insulin-resistance related 
abnormalities in both genders (21-26). Cross-sectional studies conducted in the Asia Pacific 
region (27, 28) have found a continuous relationship between central obesity and CVD risk 
factors including blood pressure, plasma glucose, plasma lipids, and insulin levels. In the present 
study, we also found the relations of cardiovascular risk factors to WC remained significant even 
after adjusting for age and BMI. Therefore, a combination of obesity and abdominal adiposity, 
i.e. central obesity, may be used as a distinctive marker for MetS, a clustering of many insulin-
resistance related risk factors (21, 29).  
 Obesity, often cited as a CVD risk factor, has long been sidelined as a useful practical 
prediction tool (30). The multinational INTERHEART case-control study confirmed the 
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importance of obesity, particularly abdominal adiposity, as a potent risk factor for myocardial 
infarction (31, 32). In addition, International Day for the Evaluation of Abdominal Obesity 
(IDEA) Study reported that BMI and particularly WC were both strongly linked to CVD and 
especially to diabetes mellitus among men and women (33). In a recent large cohort study of 
South Korean men and women, BMI was strongly related the incidence of ASCVD, including 
acute myocardial infarction, throughout its entire range (34). However, measures of BMI do not 
reveal the distribution of body fat (35). Cohort studies in the United States have found that higher 
waist-to- hip ratio (WHR) or WC are strongly associated with increased risk of IHD in women 
(36), and stroke in men (37). Swedish cohort studies have also found that the relationship with 
acute myocardial infarction (38), as well as stroke and IHD (39), is stronger for WHR than BMI. 
Our results indicate the strong and graded relation between WC and ASCVD incidence without 
specific thresholds of abrupt change in both men and women. Also, WC was significantly 
associated with the risk of IHD in men, while the association of WC to IHD was attenuated after 
further adjustment in women. The progressive association of WC with stroke was also observed 
in men and women. It is in line with some earlier studies suggesting that central obesity may 
partly explain the risk profile of coronary heart disease (35, 40, 41).  
A recent meta-analysis of MetS and risk of incident cardiovascular events and death 
suggests that people with MetS are at increased risk of cardiovascular events (42). Moreover, 
results from several studies have shown that the presence of MetS using different definitions is 
associated with a significantly increased risk of total mortality and cardiovascular morbidity and 
mortality (43).We also found that the hazard ratios of various guidelines for central obesity 
increased with higher WC for events from ASCVD, IHD and stroke in both men and women. 
Our findings are thus consistent with those of available studies on the relation between MetS and 
13 
 
CVD (44-46), and MetS is even a significant predictor of subclinical carotid atherosclerosis (47). 
In addition, Dhaliwal SS et al. (35) evaluated the role of measurements of central obesity in the 
multivariable prediction for cardiovascular risk using the Framingham risk scores. According to 
the results, WHR and WC were independent predictors of CVD deaths.  
The limitation of this study was that the prevalence of central obesity in our data does not 
reflect the general population. However, we performed the study with a large number of subjects 
relatively and the baseline characteristics of the study population were similar to the Korea 
Medical Insurance Corporation Study (34). Also, we didn’t measure hormonal status, especially 
for women, so that we could not evaluate a hormonal difference that might affect cardiovascular 
outcomes among this population. 
In conclusion, the results of the present study suggest that the association of WC with 
CVD in this cohort of Korean population was progressive over the range of WC values. As 
expected, central obesity significantly and independently contributes to cardiovascular outcomes 
in Korean men and women.  
 
 
 
 
 
 
 
 
 
 
 
 
14 
 
References 
 
      1.   World Health Organization. Obesity: Preventing and managing the global epidemic. 
Report of the WHO consultation on obesity. Geneva: Geneva, 1998. 
      2.   Bjorntorp P. Abdominal fat distribution and disease: an overview of epidemiological 
data. Ann Med 1992; 24: 15-18. 
      3.   Bjorntorp P. Abdominal fat distribution and the metabolic syndrome. J Cardiovasc 
Pharmacol 1992; 20: S26-28. 
      4.   Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional 
distribution of body fat, plasma lipoproteins, and CVD disease. Arteriosclerosis 1990; 10: 
497-511. 
      5.   Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J 
Cardiol 1999; 83: 25F-29F. 
      6.   Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple 
metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of 
correlated metabolic risk factors. Am J Epidemiol 2000; 152: 908-11; discussion 912. 
      7.   Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular 
morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 
24: 683- 9. 
      8.   Executive summary of the third report of the National Cholesterol Education Program 
(NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol 
in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486- 97. 
      9.   Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and 
its complications: Part 1. Diagnosis and classification of diabetes mellitus provisional 
report of a WHO consultation. Diabet Med 1998; 15: 539- 53. 
    10.   McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance 
with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 
382-6. 
    11.   Deurenberg-Yap M, Chew SK, Lin VF, Tan BY, van Staveren WA, Deurenberg P. 
Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore. 
Int J Obes Relat Metab Disord. 2001; 25: 1554-62. 
    12.   National Statistical Office. Annual report on the cause of death statistics. Republic of 
Korea; 2003 
    13.   Korea National Statistical Office. 2007 Report of Statistics of Mortality in Koreans, 2008 
    14.   Clinical Guidelines on the Identification. Evaluation and treatment of overweight and 
obesity in adults-the evidence report. National Institutes of Health. Obes Res 1998; 6: 
51S-209S. 
    15.   International Obesity Task Force. Asia-Pacific perspective: redefining obesity and its 
treatment. Western Pacific Region, Sydney, Australia, 2000.     
    16.   Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist 
circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 
2007; 75: 72-80. 
    17.   K.G. Alberti, P. Zimmet, J. Shaw, IDF Epidemiology Task Force Consensus Group. The 
metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062.   
    18.   WHO Expert Consultation. Appropriate body-mass index for Asian populations and its 
implications for policy and intervention strategies. Lancet 2004; 363: 157-63. 
15 
 
    19.   Deurenberg P, Deurenberg Yap M, Wang J, Lin FP, Schmidt G. The impact of body 
build on the relationship between body mass index and percent body fat. Int J Obes Relat 
Metab Disord 1999; 23: 537-42. 
    20.   Vanhala MJ, Pitkäjärvi TK, Kumpusalo EA, Takala JK. Obesity type and clustering of 
insulin resistance-associated cardiovascular risk factors in middle-aged men and women. 
Int J Obes Relat Metab Disord 1998; 22:369-74. 
    21.   BjoÈrntorp P. Abdominal obesity and the metabolic syndrome. Ann Med 1992;  24: 465-
468. 
    22.   Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 
1988; 37: 1595-1607. 
    23.   DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for 
NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. 
Diab Care 1991; 14: 173-194. 
    24.   Reaven GM. A syndrome of resistance to insulin stimulated glucose uptake (Syndrome-
X): Defnitions and implications. Cardiovascular Risk Factors 1993; 1: 2-11. 
    25.   Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective 
analysis of the insulin-resistance syndrome (Syndrome-X). Diabetes 1992; 41: 715-722. 
    26.   Laakso M. The possible pathophysiology of insulin resistance syndrome. Cardiovascular 
Risk Factors 1993; 1: 55-66. 
    27.   Thomas GN, Ho SY, Lam KSL, Janus ED, Hedley AJ, Lam TH. Impact of obesity and 
body fat distribution on cardiovascular risk factors in Hong Kong Chinese. Obesity 
Research 2004; 12: 1805-13. 
    28.   Lin W-Y, Lee L-T, Chen C-Y, Lo H, Hsia H-H, Liu I-L, et al. Optimal cut-off values for 
obesity: using simple anthropometric indices to predict cardiovascular risk factors in 
Taiwan. Int J Obesity 2002; 26: 1232-8. 
    29.   BjoÈrntorp P. ``Portal'' adipose tissue as a generator of risk factors for cardiovascular 
disease and diabetes. Arteriosclerosis 1990; 10: 493-496. 
    30.   Kannel WB, Larson M. Long-term epidemiologic prediction of coronary disease. The 
Framingham experience. Cardiology 1993; 82: 137-52. 
    31.   Yusuf  S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al.; and the 
INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27 
000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649. 
    32.   Yusuf  S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al.; and the 
INTERHEART Study Investigators. Effect of potentially modifiable risk factors 
associated with myocardial infarction in 52 countries (the INTERHEART study): 
casecontrol study. Lancet 2004; 364: 937-952. 
    33.   Balkau B, Deanfield JE, Després JP, Bassand JP, Fox KA, Smith SC Jr, et al. 
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist 
circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care 
patients in 63 countries. Circulation 2007; 116: 1942-51. 
    34.   Jee SH, Pastor-Barriuso R, Appel LJ, Suh I, Miller ER 3rd, Guallar E. Body mass index 
and incident ischemic heart disease in South Korean men and women. Am J Epidemiol 
2005; 162: 42-8. 
    35.   Dhaliwal SS, Welborn TA. Central obesity and multivariable cardiovascular risk as 
assessed by the Framingham prediction scores. Am J Cardiol 2009; 103: 1403-7. 
16 
 
    36.   Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al.  
Abdominal obesity and coronary heart disease in women. J Am Med Assoc 1998; 280:  
1843-8. 
    37.   Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC. Body size and 
fat distribution as predictors of stroke among US men. Am J Epidem 1996; 144:1143-50. 
    38.   Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of 
adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of 
participants in the population study of women in Gothenburg, Sweden. Br Med J 1984; 
289: 1257-61.  
    39.   Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal 
tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow 
up of participants in the study of men born in 1913. Br Med J 1984; 288: 1401-4. 
    40.   Ammar KA. Redfield MM. Mahoney DW. Johnson M. Jacobsen SJ. Rodeheffer RJ.  
Central obesity: association with left ventricular dysfunction and mortality in the 
community. American Heart Journal 2008; 156: 975-81.  
    41.   Asia Pacific Cohort Studies Collaboration. Central obesity and risk of cardiovascular 
disease in the Asia Pacific Region. Asia Pacific Journal of Clinical Nutrition 2006; 5: 
287-92. 
    42.   Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic 
syndrome and risk of incident cardiovascular events and death: a systematic review and 
meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-14. 
    43.   Hu G, Qiao Q, Tuomilehto J. The metabolic syndrome and cardiovascular risk. Curr 
Diabetes Rev 2005; 1: 137-43. 
    44.   Zhang WW, Liu CY, Wang YJ, Xu ZQ, Chen Y, Zhou HD. Metabolic syndrome 
increases the risk of stroke: a 5-year follow-up study in a Chinese population. J Neurol 
2009; 256: 1493-9.  
    45.   Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J. The metabolic 
syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland. 
Stroke 2008; 39: 1078-83.  
    46.   Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S; JPHC Study Group. The impact 
of the metabolic syndrome and its components on the incidence of ischemic heart disease 
and stroke: the Japan public health center-based study. Hypertens Res 2009; 32: 289-98.  
    47.   Rundek T, White H, Boden-Albala B, Jin Z, Elkind MS, Sacco RL. The metabolic 
syndrome and subclinical carotid atherosclerosis: the Northern Manhattan Study. J 
Cardiometab Syndr 2007; 2: 24-9. 
 
 
 
 
 
 
 
 
 
 
 
17 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Table 1. General characteristics of the study population at baseline 
 Men (n=30,152) Women (n=22,874) 
   Mean ± SD Mean ± SD 
Age (yrs) 43.7±10.0 44.2±11.2 
Waist circumference (cm) 84.0±8.2 75.2±8.9 
Body mass index (kg/m2 ) 23.8±2.9 23.1±3.2 
Systolic blood pressure (mm Hg) 121.9±16.6 116.0±19.1 
Diastolic blood pressure (mm Hg) 75.8±11.6 72.7±11.2 
Total cholesterol (mg/dL) 193.2±35.1 189.1±36.6 
Triglyceride (mg/dL) 155.5±111.9 114.2±77.0 
HDL cholesterol (mg/dL) 48.1±11.2 54.7±12.7 
Fasting glucose (mg/dL) 100.3±23.7 96.0±19.5 
 % % 
Smoking status   
   Ex-smoker 19.3 1.6 
   Current smoker 57.9 5.4 
Alcohol drinking (yes) 83.6 31.3 
Regular exercise (yes) 23.1 24.3 
Hypertension 26.8 21.9 
Type 2 diabetes 9.8 7.4 
HDL, high-density lipoprotein; SD, standard deviation 
 
 
2 
 
Table 2. Pearson correlations between waist circumference and cardiovascular risk factors 
 Men Women 
   Crude Age and BMI 
adjusted 
Crude Age and BMI 
adjusted 
Systolic blood pressure 0.313** 0.042** 0.425** 0.051** 
Diastolic blood pressure 0.298** 0.073** 0.332** 0.038** 
Total cholesterol  0.229** 0.058** 0.263** 0.027** 
Triglyceride 0.264** 0.078** 0.283** 0.059** 
HDL cholesterol -0.237** -0.076** -0.194** -0.039** 
Fasting glucose 0.157** 0.043** 0.226** 0.045** 
HDL, high-density lipoprotein; BMI, body mass index. 
Correlation coefficients were calculated using partial correlation analysis. 
**p < .001  
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Table 3. Hazard ratios (95% confidence intervals) of CVD by waist circumference quintiles in men 
 Waist circumference, cm  
 <78 78-82.9 83-86.9 87-90.9 ≥91  
Type of CVD (n=5,650) (n=7,015) (n=5,828) (n=5,537) (n=6,122) P value for trend 
ASCVD       
Case 164 320 328 374 490  
Rate* 373.5  566.6  641.3  747.3  842.7   
HR (95% CI)† 1.0 1.54(1.27-1.85) 1.77(1.47-2.13) 2.07(1.72-2.49) 2.32(1.94-2.78) 0.0020 
HR (95% CI)‡ 1.0 1.42(1.16-1.73) 1.54(1.24-1.91) 1.74(1.38-2.18) 1.82(1.40-2.35) 0.0100 
HR (95% CI)§  1.0 1.33(1.09-1.62) 1.41(1.14-1.75) 1.55(1.24-1.95) 1.62(1.25-2.10) 0.0118 
IHD       
  Case 82 159 169 226 278  
  Rate* 193.0  269.5  323.9  439.8  476.7   
HR (95% CI)† 1.0 1.52(1.16-1.98) 1.84(1.41-2.39) 2.54(1.97-3.27) 2.68(2.09-3.44) 0.0021 
HR (95% CI)‡ 1.0 1.35(1.02-1.78) 1.51(1.12-2.03) 1.97(1.44-2.68) 1.89(1.33-2.68) 0.0126 
HR (95% CI)§  1.0 1.27(0.96-1.67) 1.38(1.03-1.87) 1.77(1.29-2.41) 1.70(1.19-2.42) 0.0139 
Stroke       
  Case 66 130 115 128 162  
  Rate* 142.0  235.7  223.9  254.4  259.9   
HR (95% CI)† 1.0 1.59(1.18-2.14) 1.56(1.15-2.11) 1.76(1.31-2.37) 1.82(1.37-2.43) 0.0478 
HR (95% CI)‡ 1.0 1.53(1.11-2.10) 1.47(1.03-2.09) 1.63(1.12-2.37) 1.64(1.07-2.51) 0.0833 
HR (95% CI)§  1.0 1.41(1.03-1.94) 1.32(0.93-1.88) 1.41(0.97-2.06) 1.43(0.93-2.20) 0.1420 
4 
 
* Age adjusted rate per 100,000 person year 
† The Cox proportional hazards model was adjusted for age, smoking status (ex-smoker, current smoker), alcohol consumption (no, 
yes), and exercise (no, yes). 
‡ The Cox proportional hazards model was adjusted for age, smoking status (ex-smoker, current smoker), alcohol consumption (no, 
yes), exercise (no, yes), and BMI. 
§ The Cox proportional hazards model was adjusted for age, smoking status (ex-smoker, current smoker), alcohol consumption (no, 
yes), exercise (no, yes), BMI, systolic blood pressure, fasting glucose, and total cholesterol. 
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Table 4. Hazard ratios (95% CI) of CVD by waist circumference quintiles in women 
 Waist circumference, cm  
 <68 68-71.9 72-75.9 76-81.9 ≥82  
Type of CVD (n=4,586) (n=5,267) (n=5,704) (n=5,791) (n=5,623) P value for trend 
ASCVD       
  Case 77 96 186 288 399  
  Rate* 408.6  397.1  446.7  594.8  727.1   
HR (95% CI)† 1.0 1.07(0.79-1.44) 1.32(1.01-1.73) 1.80(1.38-2.33) 2.09(1.61-2.70) 0.0055 
HR (95% CI)‡ 1.0 0.96(0.71-1.31) 1.09(0.82-1.45) 1.34(1.00-1.79) 1.33(0.96-1.85) 0.0318 
HR (95% CI)§  1.0 0.96(0.71-1.30) 1.06(0.79-1.40) 1.23(0.92-1.65) 1.21(0.87-1.67) 0.0421 
IHD       
  Case 34 41 81 118 195  
  Rate* 178.0  176.3  192.4  235.8  360.0   
HR (95% CI)† 1.0 1.05(0.66-1.65) 1.33(0.89-2.00) 1.70(1.15-2.52) 2.34(1.59-3.44) 0.0129 
HR (95% CI)‡ 1.0 0.89(0.56-1.41) 0.98(0.64-1.49) 1.06(0.69-1.64) 1.14(0.70-1.84) 0.1329 
HR (95% CI)§  1.0 0.88(0.55-1.39) 0.93(0.61-1.42) 0.96(0.62-1.49) 1.01(0.62-1.64) 0.6272 
Stroke       
  Case 32 37 75 112 155  
  Rate* 185.1  161.6  179.0  228.1  252.0   
HR (95% CI)† 1.0 0.96(0.60-1.55) 1.20(0.79-1.83) 1.51(1.01-2.27) 1.74(1.16-2.59) 0.0113 
HR (95% CI)‡ 1.0 0.92(0.57-1.49) 1.11(0.71-1.72) 1.33(0.84-2.11) 1.43(0.85-2.40) 0.0232 
HR (95% CI)§  1.0 0.92(0.57-1.49) 1.08(0.69-1.68) 1.23(0.78-1.95) 1.30(0.77-2.18) 0.0308 
6 
 
* Age adjusted rate per 100,000 person year 
† The Cox proportional hazards model was adjusted for age, smoking status (ex-smoker, current smoker), alcohol consumption (no, 
yes), and exercise (no, yes). 
‡ The Cox proportional hazards model was adjusted for age, smoking status (ex-smoker, current smoker), alcohol consumption (no, 
yes), exercise (no, yes), and BMI. 
§ The Cox proportional hazards model was adjusted for age, smoking status (ex-smoker, current smoker), alcohol consumption (no, 
yes), exercise (no, yes), BMI, systolic blood pressure, fasting glucose, and total cholesterol. 
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Table 5. Hazard ratios (95% CI) of various guidelines for waist circumference (WC) 
Guideline 
 
 
WC (cm) ASCVD IHD Stroke 
NCEP Men <102 1.00 1.00 1.00 
  ≥102 1.79(1.36-2.36) 1.65(1.13-2.43) 1.85(1.19-2.86) 
 Women <88 1.00 1.00 1.00 
  ≥88 1.55(1.33-1.80) 1.93(1.56-2.39) 1.39(1.08-1.76) 
APC Men <90 1.00 1.00 1.00 
  ≥90 1.47(1.33-1.63) 1.66(1.45-1.90) 1.20(1.01-1.42) 
 Women <80 1.00 1.00 1.00 
  ≥80 1.61(1.42-1.83) 1.74(1.44-2.11) 1.51(1.23-1.85) 
Korean Men <90 1.00 1.00 1.00 
  ≥90 1.47(1.33-1.63) 1.66(1.45-1.90) 1.20(1.01-1.42) 
 Women <85 1.00 1.00 1.00 
  ≥85 1.56(1.36-1.78) 1.96(1.61-2.38) 1.43(1.15-1.77) 
*adjusted for age, smoking status, alcohol intake and exercise. 
NCEP, National Cholesterol Education Program Adult Treatment Panel III criteria; APC, 
Asia-Pacific criteria 
 
 
 
  
 
 
 
 
Figure 1. Distribution of waist circumference in men and women 
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